Biocon Ltd

BIOCON

Company Profile

  • Business description

    Biocon Ltd is a biopharmaceutical company that develops biotechnology therapies for diseases. The company is focused on developing, manufacturing, and supplying novel and biosimilar pharmaceuticals for diabetes, cancer, and autoimmune conditions. Biocon has four reportable segments: Biosimilars which derives maximum revenue, Generics, Novel Biologics (Novels), and Research services (Research). The company provides integrated contract research and manufacturing services to pharmaceutical and biotechnology companies through its subsidiary Syngene. Geographically, the company generates a majority of its revenue from its customers located in India and the rest from Brazil, Singapore, and the rest of the world.

  • Contact

    20th KM, Hosur Road
    Electronics City
    BengaluruKA560100
    IND

    T: +91 8028082808

    https://www.biocon.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 March 2025

    Employees

    9,805

Stocks News & Analysis

video

What does the RBA rate cut mean for investors?

Morningstar's Chief Investment Officer for Asia-Pacific and Director of Personal Finance share their thoughts on the recent RBA rate cut.
stocks

Insights from reporting season: So far, so good

We’ve upgraded our fair value estimate for 29 companies, or 40% of those that have reported thus far.
stocks

3 cheap ASX stocks owned by top rated funds

Our analysts think these companies are undervalued and their shares appear to have the stamp of approval from highly rated managers.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,570.9030.80-0.36%
CAC 408,154.5131.930.39%
DAX 4022,287.5627.09-0.12%
Dow JONES (US)43,725.89450.76-1.02%
FTSE 1008,659.373.60-0.04%
HKSE23,477.92900.943.99%
NASDAQ19,764.02198.34-0.99%
Nikkei 22538,776.9498.900.26%
NZX 50 Index12,752.58127.78-0.99%
S&P 5006,071.3246.20-0.76%
S&P/ASX 2008,296.2026.60-0.32%
SSE Composite Index3,379.1128.330.85%

Market Movers